1. Home
  2. Analysis
  3. Docetaxel
  4. Pyoderma-gangrenosum

Docetaxel and Pyoderma gangrenosum - a phase IV clinical study of FDA data

Summary:

Pyoderma gangrenosum is reported as a side effect among people who take Docetaxel (docetaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Codeine, and have Constipation.

The phase IV clinical study analyzes which people have Pyoderma gangrenosum when taking Docetaxel. It is created by eHealthMe based on reports of 79,811 people who have side effects when taking Docetaxel from the FDA, and is updated regularly.

What is Docetaxel?

Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.

What is Pyoderma gangrenosum?

Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance) is found to be associated with 305 drugs and 348 conditions by eHealthMe. Check the latest studies of Pyoderma gangrenosum.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

79,811 people reported to have side effects when taking Docetaxel.
Among them, 12 people (0.02%) have Pyoderma gangrenosum.

Could Docetaxel cause Pyoderma gangrenosum?

Among these 12 people:

How long have people been on Docetaxel when they have Pyoderma gangrenosum? *

  • < 1 month: 33.33 %
  • 1 - 6 months: 66.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pyoderma gangrenosum when taking Docetaxel? *

  • female: 54.55 %
  • male: 45.45 %

What is the age of people who have Pyoderma gangrenosum when taking Docetaxel? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 0.0 %
  • 60+: 81.82 %

What are other drugs people take besides Docetaxel? *

  1. Codeine: 2 people, 16.67%
  2. Ramipril: 1 person, 8.33%
  3. Prednisone: 1 person, 8.33%
  4. Plavix: 1 person, 8.33%
  5. Gabapentin: 1 person, 8.33%
  6. Dexamethasone: 1 person, 8.33%
  7. Cyclophosphamide: 1 person, 8.33%
  8. Codeine Sulfate: 1 person, 8.33%
  9. Claritin: 1 person, 8.33%
  10. Cephalexin: 1 person, 8.33%

What are other side effects people have besides Pyoderma gangrenosum? *

  1. Stomatitis (inflammation of mucous membrane of mouth): 5 people, 41.67%
  2. Pain: 5 people, 41.67%
  3. Bone Pain: 5 people, 41.67%
  4. Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 5 people, 41.67%
  5. Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 8.33%
  6. Rashes (redness): 1 person, 8.33%
  7. Pain In Extremity: 1 person, 8.33%
  8. Necrosis (the death of body tissue): 1 person, 8.33%
  9. Mouth Ulcers: 1 person, 8.33%
  10. Gangrene (body tissue dies): 1 person, 8.33%

What are the existing conditions these people have? *

  1. Tachycardia Paroxysmal (a form of tachycardia which begins and ends in an acute (or paroxysmal) manner): 4 people, 33.33%
  2. Oedema (fluid collection in tissue): 4 people, 33.33%
  3. Malignant Pleural Effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung): 4 people, 33.33%
  4. Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 33.33%
  5. High Blood Cholesterol: 4 people, 33.33%
  6. Enlarged Prostate: 4 people, 33.33%
  7. Constipation: 4 people, 33.33%
  8. Prostate Cancer: 1 person, 8.33%
  9. Pain: 1 person, 8.33%
  10. Breast Cancer Stage Ii: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Docetaxel and have Pyoderma gangrenosum?

- Check whether Pyoderma gangrenosum is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Docetaxel:

Pyoderma gangrenosum treatments and more:

How severe was Pyoderma gangrenosum and when was it recovered:

Expand to all the drugs that have ingredients of docetaxel:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Docetaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyoderma gangrenosum:

Browse all the conditions that are associated with Pyoderma gangrenosum:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Docetaxel) and Docetaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.